Consensus Theralase Technologies Inc.
Stocks
TLT
CA88337V1004
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2850 CAD | +1.79% |
|
+7.55% | +72.73% |
| 05-29 | Theralase Technologies Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 05-20 | Theralase Technologies Raises $4.8 Million Via Brokered Private Placement Offering | MT |
Evolution of the Average Target: Theralase Technologies Inc.
Evolution of the Target Price: Theralase Technologies Inc.
Changes in Analyst Recommendations: Theralase Technologies Inc.
167073c7c4e0ee126049.05wulbKxKsxzHALl0Rzux3BJxVOcYJkkCKvJ2ohsIno.q6x_0uuHRPUXTjbVjnHbvQYO_DLzAthcR-7wvuI-ay6S5UKhyvJNnjEuMg~637ffea762ace8e89cf9d73aa535773a
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
| - | - | +145.61% | ||||
| +13.42% | ||||||
| - | +52.38% | |||||
| Average | +70.47% | |||||
| Weighted average by Cap. | +19.85% |
Analysts' Consensus
Sell
Buy

Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.2850CAD
Average target price
0.7000CAD
Spread / Average Target
+145.61%
High Price Target
0.7000CAD
Spread / Highest target
+145.61%
Low Price Target
0.7000CAD
Spread / Lowest Target
+145.61%
Analyst Consensus Detail
Consensus revision (last 18 months)
Sell
Buy

Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.2850CAD
Average target price
0.7000CAD
Spread / Average Target
+145.61%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TLT Stock
- Consensus Theralase Technologies Inc.
Select your edition
All financial news and data tailored to specific country editions
















